UA99487C2 - Кристалічний хіміотерапевтичний засіб$кристаллическое химиотерапевтическое средство - Google Patents
Кристалічний хіміотерапевтичний засіб$кристаллическое химиотерапевтическое средствоInfo
- Publication number
- UA99487C2 UA99487C2 UAA201005821A UAA201005821A UA99487C2 UA 99487 C2 UA99487 C2 UA 99487C2 UA A201005821 A UAA201005821 A UA A201005821A UA A201005821 A UAA201005821 A UA A201005821A UA 99487 C2 UA99487 C2 UA 99487C2
- Authority
- UA
- Ukraine
- Prior art keywords
- chemotherapeutic agent
- crystalline
- crystalline chemotherapeutic
- ways
- indazol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98124307P | 2007-10-19 | 2007-10-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
UA99487C2 true UA99487C2 (xx) | 2012-08-27 |
Family
ID=40242659
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201005821A UA99487C2 (xx) | 2007-10-19 | 2008-10-16 | Кристалічний хіміотерапевтичний засіб$кристаллическое химиотерапевтическое средство |
Country Status (20)
Country | Link |
---|---|
US (1) | US7943782B2 (ru) |
EP (1) | EP2195297A1 (ru) |
JP (1) | JP2011500706A (ru) |
KR (1) | KR20100102098A (ru) |
CN (1) | CN101827823B (ru) |
AU (1) | AU2008312532A1 (ru) |
BR (1) | BRPI0818343A2 (ru) |
CA (1) | CA2699353A1 (ru) |
CO (1) | CO6280483A2 (ru) |
CR (1) | CR11386A (ru) |
DO (1) | DOP2010000116A (ru) |
GT (1) | GT201000101A (ru) |
MX (1) | MX2010004289A (ru) |
MY (1) | MY153098A (ru) |
PA (1) | PA8800501A1 (ru) |
RU (1) | RU2010119917A (ru) |
SG (1) | SG185326A1 (ru) |
UA (1) | UA99487C2 (ru) |
WO (1) | WO2009052229A1 (ru) |
ZA (1) | ZA201002092B (ru) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10166142B2 (en) | 2010-01-29 | 2019-01-01 | Forsight Vision4, Inc. | Small molecule delivery with implantable therapeutic device |
US20140031769A1 (en) | 2010-11-19 | 2014-01-30 | Forsight Vision4, Inc. | Therapeutic agent formulations for implanted devices |
EP2968113B8 (en) | 2013-03-14 | 2020-10-28 | Forsight Vision4, Inc. | Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant |
SG11201700943TA (en) | 2014-08-08 | 2017-03-30 | Forsight Vision4 Inc | Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1503762A2 (en) * | 2002-05-10 | 2005-02-09 | Teva Pharmaceutical Industries Ltd. | Novel crystalline forms of gatifloxacin |
KR20060028761A (ko) * | 2003-05-08 | 2006-04-03 | 아이박스 파마슈티컬스 에스.알.오. | 다형의 카베르골린 |
EP2246333B1 (en) * | 2003-05-22 | 2012-10-24 | Abbott Laboratories | Indazole, benzisoxazole, and benzisothiazole kinase inhibitors |
US7297709B2 (en) | 2003-05-22 | 2007-11-20 | Abbott Laboratories | Indazole, benzisoxazole, and benzisothiazole kinase inhibitors |
DE102005033100B3 (de) * | 2005-07-15 | 2007-01-25 | Sanofi-Aventis Deutschland Gmbh | Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, diese Verbindung enthaltene Arzneimittel und Verfahren zu deren Herstellung |
US20100105031A1 (en) * | 2005-08-01 | 2010-04-29 | Esai R & D Management Co., Ltd. | Method for prediction of the efficacy of vascularization inhibitor |
JP4989476B2 (ja) * | 2005-08-02 | 2012-08-01 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 血管新生阻害物質の効果を検定する方法 |
JP2009513642A (ja) | 2005-10-25 | 2009-04-02 | アボット・ラボラトリーズ | 低水溶解度の薬剤を含む製剤およびそれの使用方法 |
WO2007076358A1 (en) * | 2005-12-23 | 2007-07-05 | Alcon, Inc. | PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE |
EP1984342A2 (en) * | 2006-01-20 | 2008-10-29 | Janssen Pharmaceutica, N.V. | Novel solid forms of (4r)-1-[4-(2-chloro-5-fluorobenzoyl)amino-3-methoxybenzoyl]-1,2,3,5-tetrahydro-spiro[4h-1-benzazepine-4,1'-[2]cyclopentene]-3'-carboxylic acid |
EP2089003A1 (en) * | 2006-11-09 | 2009-08-19 | Abbott GmbH & Co. KG | Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor |
-
2008
- 2008-10-15 US US12/251,964 patent/US7943782B2/en not_active Expired - Fee Related
- 2008-10-16 MX MX2010004289A patent/MX2010004289A/es active IP Right Grant
- 2008-10-16 BR BRPI0818343A patent/BRPI0818343A2/pt not_active IP Right Cessation
- 2008-10-16 WO PCT/US2008/080066 patent/WO2009052229A1/en active Application Filing
- 2008-10-16 EP EP08839149A patent/EP2195297A1/en not_active Withdrawn
- 2008-10-16 KR KR1020107010994A patent/KR20100102098A/ko not_active Application Discontinuation
- 2008-10-16 CN CN2008801119449A patent/CN101827823B/zh not_active Expired - Fee Related
- 2008-10-16 CA CA2699353A patent/CA2699353A1/en not_active Abandoned
- 2008-10-16 JP JP2010530092A patent/JP2011500706A/ja active Pending
- 2008-10-16 MY MYPI20101652 patent/MY153098A/en unknown
- 2008-10-16 RU RU2010119917/04A patent/RU2010119917A/ru not_active Application Discontinuation
- 2008-10-16 UA UAA201005821A patent/UA99487C2/ru unknown
- 2008-10-16 SG SG2012078200A patent/SG185326A1/en unknown
- 2008-10-16 AU AU2008312532A patent/AU2008312532A1/en not_active Abandoned
- 2008-10-17 PA PA20088800501A patent/PA8800501A1/es unknown
-
2010
- 2010-03-24 ZA ZA2010/02092A patent/ZA201002092B/en unknown
- 2010-04-16 DO DO2010000116A patent/DOP2010000116A/es unknown
- 2010-04-16 GT GT201000101A patent/GT201000101A/es unknown
- 2010-04-23 CR CR11386A patent/CR11386A/es not_active Application Discontinuation
- 2010-04-27 CO CO10049265A patent/CO6280483A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2008312532A1 (en) | 2009-04-23 |
CN101827823B (zh) | 2012-10-03 |
CO6280483A2 (es) | 2011-05-20 |
DOP2010000116A (es) | 2010-05-31 |
GT201000101A (es) | 2012-03-26 |
ZA201002092B (en) | 2011-11-30 |
RU2010119917A (ru) | 2011-11-27 |
KR20100102098A (ko) | 2010-09-20 |
MY153098A (en) | 2014-12-31 |
CR11386A (es) | 2010-08-18 |
EP2195297A1 (en) | 2010-06-16 |
CA2699353A1 (en) | 2009-04-23 |
BRPI0818343A2 (pt) | 2017-05-23 |
JP2011500706A (ja) | 2011-01-06 |
US7943782B2 (en) | 2011-05-17 |
US20090105486A1 (en) | 2009-04-23 |
SG185326A1 (en) | 2012-11-29 |
PA8800501A1 (es) | 2009-05-15 |
CN101827823A (zh) | 2010-09-08 |
MX2010004289A (es) | 2010-04-30 |
WO2009052229A1 (en) | 2009-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200745028A (en) | Novel sulphonylpyrroles | |
EP1845086A4 (en) | N-SUBSTITUTED N-METHOXYCARBAMATES BY 2-SUBSTITUTED PHENYL GROUPS, THEIR SYNTHESIS AND THEIR APPLICATIONS | |
TW200745027A (en) | Novel sulphonylpyrroles | |
TW200615264A (en) | N-(ortho-phenyl)-1-methyl-3-difluoromethylpyrazole-4-carboxanilides and their use as fungicides | |
MX2007005932A (es) | 1-alquinil-2-ariloxialquilamidas y su uso como fungicidas. | |
IL185275A0 (en) | N-sulphonylpyrrole derivatives and pharmaceutical compositions containing the same | |
TW200600499A (en) | Novel amido-substituted hydroxy-6-phenylphenanthridines | |
WO2005087724A3 (en) | Sulphonylpyrroles as hdac inhibitors | |
SI2201018T1 (sl) | Trdne oblike, ki obsegajo N-(5-terc.butil-izoksazol-3-il)-N'-(4-Y7-(2- morfolin-4-il-etoksi)imidazoY2,1-B"Y 1,3"benzotiazol-2-ilfenil)sečnina, njihove sestave in uporabe z njimi | |
UA102858C2 (ru) | Производные пиридино-пиридинонов, способ их получения и применения в терапии | |
RS50629B (sr) | Amidni prolek gemcitabina, kompozicije i njihova primena | |
DK1585737T3 (da) | Uraciler med herbicid virkning | |
TW200619206A (en) | Chemokine-binding heterocyclic compound salts, and methods of use thereof | |
TW200715966A (en) | Synergistic fungicidal active compound combinations | |
IL200469A0 (en) | Benzimidazole derivatives | |
SI1912644T1 (sl) | Derivati N-(arilalkil)-1H-pirolopiridin-2-karboksamidov, njihova priprava in njihova terapevtska uporaba | |
UA99487C2 (xx) | Кристалічний хіміотерапевтичний засіб$кристаллическое химиотерапевтическое средство | |
UA99489C2 (en) | Crystalline chemotherapeutic agent | |
UA99490C2 (en) | Crystalline chemotherapeutic agent | |
CL2008003091A1 (es) | Forma cristalina 1 de etanolato de n-(4-(3-amino-1h-indazol-4il)fenil)-n-(2-fluoro-5-metilfenil)urea. 1/4; composicion farmaceutica; y uso en el tratamiento de cancer en un mamifero. | |
EP1900735A4 (en) | PYRIDAZINYLAMINE DERIVATIVES, USE OF DERIVATIVES IN THE PREPARATION OF PICORNAVIRUS INHIBITORS | |
GB0514743D0 (en) | Salt | |
UA99746C2 (ru) | Кристаллическое химиотерапевтическое средство на основе индазола | |
TW200607499A (en) | 2-(1H-indolylsulfanyl)-benzyl amine derivatives | |
ATE348803T1 (de) | Tryptase-inhibitoren |